Form 4: Teladoc Health Director Acquires Restricted Stock Units

Sandra L. Fenwick, a director of Teladoc Health, Inc., acquired 17,467 restricted stock units on May 23, 2024, which will vest on the earlier of May 23, 2025, or the day before the 2025 annual meeting of stockholders.

Summary

• On May 23, 2024, Sandra L. Fenwick, a director of Teladoc Health, Inc., acquired 17,467 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of TDOC common stock.
• The RSUs will vest in full on the earlier of May 23, 2025, or the day immediately preceding the issuer's 2025 annual meeting of stockholders.
• Vested shares will be delivered to the reporting person under specific conditions, including separation of service, a change of control, or death.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring stock units is generally a good sign, indicating confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of restricted stock units by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units is contingent upon continued service or specific events such as a change of control or death.

Industry Context

Director stock acquisitions are common in the healthcare industry and are often seen as a positive sign of management's belief in the company's prospects.

Stakeholder Impact

• The acquisition of restricted stock units by a director can positively influence shareholder sentiment.

Key Dates